Positioning ganglioside D3 as an immunotherapeutic target in lymphangioleiomyomatosis.
Gilbert ER, Eby JM, Hammer AM, Klarquist J, Christensen DG, Barfuss AJ, Boissy RE, Picken MM, Love RB, Dilling DF, Le Poole IC.
Gilbert ER, et al.
Am J Pathol. 2013 Jul;183(1):226-34. doi: 10.1016/j.ajpath.2013.04.002. Epub 2013 May 10.
Am J Pathol. 2013.
PMID: 23665200